Skip to main content

Showing results for Breast Cancer Research

Biostatistics Summer Workshop

Save the Date (June 10-21, 2024) for Advanced Statistics Summer Workshop

Lisa Gill  |  Mar 08, 2024

Mutations, mammograms and MRIs, oh my! How I took charge of my breast health with increased screenings, and when you should do the same

Christina Griffiths is a media relations specialist for Indiana University School of Medicine and has worked with the office of strategic communications for five years. She wrote the following story about her experience learning she is at a high risk of developing breast cancer during her lifetime, and the increased screenings that began as a result.

Christina Griffiths  |  Oct 25, 2023

MOVE program brightens outlook for breast cancer patients

The Multidisciplinary Oncology Vitality and Exercise (MOVE) Program, developed by oncologist Tarah Ballinger, MD, gives breast cancer patients a personalized plan for exercise and physical therapy throughout all stages of their cancer journey.

Laura Gates  |  Oct 04, 2022

Q&A with Michele Coté, PhD

Michele Coté, PhD, is just getting started in her new role as the second director of the Susan G. Komen Tissue Bank at IU Simon Comprehensive Cancer CenterAn internationally recognized molecular cancer epidemiologist and health disparities researcher, she began at IU on Sept. 1.

Candace Gwaltney  |  Sep 01, 2022

Hassanein receives scientific research grant designed to overcome COVID disruptions

Research scientists and those with dependents were significantly impacted by COVID-19 – spending roughly 40 percent less time on studies. To address this challenge, the Doris Duke Charitable Foundation (DDCF), through the support of the John Templeton Foundation, administered a grant called the “Fund to Retain Clinical Scientists” to extend research capacity among medical scientists who had experienced a surge in family caregiving and other research disruptions during the pandemic. Al Hassanein, MD, assistant professor of Surgery in the Division of Plastic Surgery at the Indiana University School of Medicine was among the grant recipients to receive a FRCS grant, which was facilitated by the Indiana Clinical and Translational Sciences Institute at Indiana University to support junior investigators.

Angie Antonopoulos  |  Apr 12, 2022

Black patients play key role in advancing breast cancer research

Community advocates are partnering with Indiana University School of Medicine to spread the word about the importance of including Black women in clinical research for breast cancer as researchers affiliated with the Vera Bradley Foundation Center for Breast Cancer Research are studying how treatments can be tailored for people of different ethnicities to fight breast cancer more effectively and with fewer side effects. 

Laura Gates  |  Oct 25, 2021

'Whac-a-Mole' clinical trial participant experiences remission of Stage 4 triple negative breast cancer

Jenny Larner Brown dreams of a day when no one would ever hear their oncologist say, "We're out of options." It's now been more than two years since Brown learned she had deadly Stage 4 triple negative breast cancer. She remains in remission today, thanks to her participation in an IU School of Medicine clinical trial called "Whac-a-Mole."

Laura Gates  |  Oct 19, 2021

Dr. Marino, others demonstrate the importance of studying the “normal breast”

Natascia Marino, PhD, assistant research professor of medicine at IU School of Medicine and a research scientist with the Komen Tissue Bank at the IU Simon Cancer Center, is among the authors of a study published online in npj Breast Cancer. Dr. Marino said the study demonstrates the importance of conducting research on the “normal breast” and that she and her colleagues were surprised by the role fat plays in the development of breast cancer. 

Michael Schug  |  Nov 10, 2020

Genomic medicine key to treating aggressive breast cancers disproportionately affecting African American women

Compared to white women, the lifetime risk of developing breast cancer is slightly lower for African Americans; however, the risk of dying from the disease is higher for African American women. For years, the medical community thought these disparities could be solely attributed to socioeconomic factors, but current research tells a much more complex story.

Laura Gates  |  Oct 09, 2020